PMLiVE3d
AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections
AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...
MM&M11h
Pharma brands are struggling to keep the attention of digitally savvy HCPs
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...
pharmaphorum6d
AbbVie lines up Thakkar to replace outgoing CSO Hudson
There is change at the top of AbbVie’s R&D organisation ... He has an excellent track record in building new capabilities, forging strategic partnerships, and advancing our clinical programmes ...
pharmaphorum4d
Share in cystic fibrosis firm Sionna rise sharply after IPO
Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...
Pharmabiz1d
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Business Wire3d
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Top Investments to Fill Your TFSA Contribution Room in 2025
Here's a basket of top investments to consider for your TFSA in 2025 from low risk to high risk. The post Top Investments to ...
FiercePharma4d
AbbVie scores FDA nod for Pfizer-partnered antibiotic Emblaveo
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., winning an ...
Pharmaceutical Technology5d
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
Credit: Studio Romantic/Shutterstock. AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in conjunction with metronidazole for people ...